A Survey of Physicians Understanding of the Regulatory Systems for Clinical Trials in Japan

スポンサーリンク

概要

• 論文の詳細を見る

• Background: Re-revision of the Ethical Guidelines for Clinical Study (EGCS) in Japan is planned in 2013. It is important to ascertain the current situation of physicians understanding to conduct clinical trials. It seems that the difference in regulatory processes between commercial and non-commercial clinical trials has caused significant confusion for physicians in conducting clinical trials in Japan.This survey was undertaken in order to improve awareness of the differences between both types of clinical trials. Furthermore, this survey examined whether it was effective to promote about clinical trials under newly introduced regulatory guidelines and to examine the subsequent willingness of physicians to conduct such clinical trials.Methods: From 24th March to 24th April 2009 inclusive, a questionnaire survey was conducted targeting 286 physicians working at Shiga University of Medical Science Hospital. A follow-up survey was conducted among 109 participants at a lecture about clinical trials on 8th July 2009.Results: Physicians who had prior knowledge of the regulations, purposes, or support systems for commercial and non-commercial clinical trials responded positively that they were more likely to conduct clinical trials, while physicians who had no prior knowledge of them responded negatively. Both groups reported that their daily working pressures and cumbersome regulatory processes prevented them from conducting clinical trials.Conclusion: Japanese physicians lack knowledge and information about clinical trials, leading to negative perceptions and reduced willingness to conduct such studies. Thus, the introduction of any strict and complex regulations should be approached carefully when the environment for clinical trials has not yet been established.

• 一般社団法人 日本プライマリ・ケア連合学会の論文

著者

• Kawakami Koji

  Department Of Otorhinolaryngology Yokohama City University School Of Medicine

• Hinotsu Shiro

  Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University

• NAKAGAWA Masao

  Shiga University

• Urushihara Hisashi

  Department of Pharmacoepidemiology, Kyoto University School of Public Health, Japan

• Yamauchi Yukie

  Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University

• Kawashima Yumie

  Shiga University of Medical Science Hospital

• Uosaki Fumiyo

  Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University

• Kobayashi Yasutoshi

  Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University

• Urushihara Hisashi

  Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University

関連論文

• Antedrug Budesonide by Intrapulmonary Treatment Attenuates Bleomycin-Induced Lung Injury in Rats with Minimal Systemic Adverse Effects
• COMEDOGENICITY OF SQUALENE MONOHYDROPEROXIDE IN THE SKIN AFTER TOPICAL APPLICATION
• Good Laboratory Practice (GLP) status of Asian countries and its implementation in non-clinical safety studies in pharmaceutical drug development
• Tissue elasticity imaging for diagnosis of prostate cancer : A preliminary report
• An Antioxidant, Probucol, Induces Anti-angiogenesis and Apoptosis in Athymic Nude Mouse Xenografted Human Head and Neck Squamous Carcinoma Cells
• A Selective Cyclooxygenase-2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells
• How many uncomplicated male and female overactive bladder patients reveal detrusor overactivity during urodynamic study?
• Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer
• Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract : A single institutional retrospective long-term follow-up study
• Evidence-based clinical practice guidelines for bladder cancer (Summary - JUA 2009 Edition)
• S14-1 Recurrence hazards of superficial bladder cancer after TURBT(Symposium 14「Management of Superficial Bladder Cancer」)
• Echocardiography for the Detection of Valvulopathy Associated with the Use of Ergot-Derived Dopamine Agonists in Patients with Parkinsons Disease
• Therapeutic Use of Flexible Cystoscope
• Characterization of a novel Neuropilin-1 targeted hybrid peptide disintegrating cancer cell membrane
• Antitumor effect of the EGFR-lytic hybrid peptide in animal model of human cancers with K-ras mutation
• Effective in vitro and in vivo Antitumor Activity of Hybrid IL4-lytic Peptide
• Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol : a report from the JWiTS Group
• Human Cognitive Reliability Analysis on Drivers Using Simulator Experiments(Theory and Methodology,The 40th International Conference on Computers and Industrial Engineering (CIE 40))
• Cytotoxic activity to acute myeloid leukemia cells by Antp-TPR hybrid peptide targeting Hsp90(MEDICAL BIOTECHNOLOGY)
• A Survey of Physicians Understanding of the Regulatory Systems for Clinical Trials in Japan
• Tryptophan Inhibits the (3H)Glutamate Uptake into Xenopus Oocytes Injected with Rat Brain mRNA.
• Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinoma

もっと見る 閉じる

スポンサーリンク